The COVID-19 pandemic created ripple effects across all of health care, especially for at-risk populations like cancer patients. Early in the pandemic, the National Cancer Institute initiated a study to examine the intersection of cancer and COVID-19 diagnoses. More than two years later, we discuss with NCI Head of Breast Cancer and Melanoma Therapeutics Dr. Larissa Korde from the Clinical Investigations Branch on the status of the study, some of the preliminary findings and how it’s evolved.
Cancer HealthCast
26m listen
A Look Into COVID-19’s Impact on Cancer Patients
An NCI study examines the crossroads between cancer and COVID-19 diagnoses.
-
Dr. Larissa Korde Head, Breast Cancer and Melanoma Therapeutics NCI
Related Content
-
GSA Cloud Chief Talks FedRAMP 2.0, Automation Hub
Eric Mill shares how a new pilot will inform continuous assessments plus more on software development resources and generative AI.
24m listen -
Boosting the Public Sector Cybersecurity Workforce
ISC2's Tara Wisniewski spoke about skills-based hiring in cybersecurity and how agencies can hire cyber pros easier.
11m listen -
NIST Center Helps Translate Cyber Standards into Practice
Interagency agreements and the collaboration model at the National Cybersecurity Center of Excellence advance cybersecurity.
15m listen -
DISA Using AI to Secure Multi-Cloud Environments
The Defense Information Systems Agency is harnessing artificial intelligence to secure multi-cloud environments.
13m listen
